NYSE · CIK 0000906107
VMRK EQUITY RESIDENTIAL
Insider trading from SEC Form 4. Last filing 31 d ago. Close $61.16 on Oct 9, 2026, +9% from the 52-week low and -12% from the high.
Last 90 days
Net insider value
-$74k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$74k by 1 insider
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
VMRKOct 9, 2026 · close 61.16
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at EQUITY RESIDENTIAL, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Chris Carr director sell | $74k 1,130 shares | -20% | - | |
| 33Weak | Catherine Carraway EVP & CHRO sell | $71k 1,007 shares | -7% | +14% from low-7% from high | |
| 17Weak | Robert Garechana EVP & Chief Financial Officer buy | $279 4 shares | +0% | - | |
| 69Notable | Alexander Brackenridge Executive Vice President & CIO sell | $898k 12,459 shares | -13% | - | |
| 47Moderate | Catherine Carraway EVP & CHRO sell | $61k 845 shares | -6% | - | |
| 36Weak | Stephen E Sterrett director sell | $152k 2,101 shares | -10% | - | |
| 61Notable | Scott Fenster EVP & General Counsel sell | $385k 5,340 shares | -13% | - | |
| 66Notable | Robert Garechana EVP & Chief Financial Officer sell | $309k 4,294 shares | -23% | - | |
| 46Moderate | Ian Kaufman Chief Accounting Officer sell | $46k 642 shares | -2% | - | |
| 76Notable | Michael L Manelis Executive Vice President & COO sell | $684k 9,487 shares | -26% | - | |
| 41Moderate | Michael L Manelis Executive Vice President & COO sell | $143k 2,000 shares | -7% | - |
Transactions
The last 61 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivativeindirect: LLC | -1,325 | $0.00 | $0 | 86,745 | 31 d ago |
| Sep 9, 2026 | Chris Carr director | SOpen-market sale Common Shares Of Beneficial Interest | -1,130 | $65.28 | $74k | 4,461 | 31 d ago |
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivativeindirect: 2020 DN GRAT | +1,325 | $0.00 | $0 | 1,333 | 31 d ago |
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivativeindirect: 2020 DN GRAT | -1,322 | $0.00 | $0 | 11 | 31 d ago |
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivative | +1,322 | $0.00 | $0 | 426,412 | 31 d ago |
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivativeindirect: LLC | -1,325 | $0.00 | $0 | 85,420 | 31 d ago |
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivativeindirect: 2020A DN GRAT | +1,325 | $0.00 | $0 | 2,752 | 31 d ago |
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivativeindirect: 2020A DN GRAT | -977 | $0.00 | $0 | 1,775 | 31 d ago |
| Sep 9, 2026 | David J Neithercut director | GGift Operating Partnership Unitsderivative | +977 | $0.00 | $0 | 427,389 | 31 d ago |
| Aug 31, 2026 | Scott Fenster EVP & General Counsel | AGrant or award Common Shares Of Beneficial Interest | +4,584 | $0.00 | $0 | 23,022 | 40 d ago |
| Aug 31, 2026 | Michael L Manelis Executive Vice President & COO | AGrant or award Common Shares Of Beneficial Interest | +10,536 | $0.00 | $0 | 55,249 | 40 d ago |
| Aug 31, 2026 | Michael L Manelis Executive Vice President & COO | AGrant or award Common Shares Of Beneficial Interest | +10,820 | $0.00 | $0 | 66,069 | 40 d ago |
| Aug 31, 2026 | Michael L Manelis Executive Vice President & COO | AGrant or award Common Shares Of Beneficial Interest | +13,201 | $0.00 | $0 | 79,270 | 40 d ago |
| Aug 31, 2026 | Scott Fenster EVP & General Counsel | AGrant or award Restricted Unitsderivative | +9,233 | $0.00 | $0 | 9,233 | 40 d ago |
| Aug 31, 2026 | Michael L Manelis Executive Vice President & COO | AGrant or award Restricted Unitsderivative | +11,055 | $0.00 | $0 | 11,055 | 40 d ago |
| Aug 31, 2026 | Scott Fenster EVP & General Counsel | AGrant or award Restricted Unitsderivative | +4,792 | $0.00 | $0 | 4,792 | 40 d ago |
| Aug 31, 2026 | Scott Fenster EVP & General Counsel | AGrant or award Restricted Unitsderivative | +14,397 | $0.00 | $0 | 14,397 | 40 d ago |
| Aug 31, 2026 | Michael L Manelis Executive Vice President & COO | AGrant or award Restricted Unitsderivative | +11,310 | $0.00 | $0 | 11,310 | 40 d ago |
| Aug 31, 2026 | Michael L Manelis Executive Vice President & COO | AGrant or award Restricted Unitsderivative | +13,805 | $0.00 | $0 | 13,805 | 40 d ago |
| May 14, 2025 | Ian Kaufman Chief Accounting Officer | AGrant or award Common Shares Of Beneficial Interest | +24 | $58.70 | $1,409 | 25,683 | May 15, 2025 |
| May 1, 2025 | Catherine Carraway EVP & CHRO | SOpen-market sale Common Shares Of Beneficial Interest | -1,007 | $70.55 | $71k | 12,746 | May 5, 2025 |
| Mar 17, 2025 | Robert Garechana EVP & Chief Financial Officer | POpen-market purchase Common Shares Of Beneficial Interest | +4 | $69.81 | $279 | 14,112 | Mar 26, 2025 |
| Feb 28, 2025 | Ian Kaufman Chief Accounting Officer | AGrant or award Common Shares Of Beneficial Interest | +119 | $62.55 | $7,443 | 25,659 | Mar 4, 2025 |
| Feb 28, 2025 | Mark S Shapiro director | AGrant or award Common Shares Of Beneficial Interest | +1,598 | $62.55 | $100k | 18,935 | Mar 4, 2025 |
| Feb 5, 2025 | Barry Altshuler Executive Vice President | AGrant or award Restricted Unitsderivative | +3,967 | $0.00 | $0 | 3,967 | Feb 7, 2025 |
| Feb 5, 2025 | Alexander Brackenridge Executive Vice President & CIO | AGrant or award Common Shares Of Beneficial Interest | +20,971 | $0.00 | $0 | 94,968 | Feb 7, 2025 |
| Feb 5, 2025 | Catherine Carraway EVP & CHRO | AGrant or award Common Shares Of Beneficial Interest | +3,943 | $0.00 | $0 | 14,598 | Feb 7, 2025 |
| Feb 5, 2025 | Stephen E Sterrett director | MOption exercise Common Shares Of Beneficial Interest | +2,101 | $68.40 | $144k | 21,496 | Feb 7, 2025 |
| Feb 5, 2025 | Mark J. Parrell President & CEO | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +113,455 | $0.00 | $0 | 113,455 | Feb 7, 2025 |
| Feb 5, 2025 | Ian Kaufman Chief Accounting Officer | AGrant or award Common Shares Of Beneficial Interest | +3,827 | $0.00 | $0 | 26,181 | Feb 7, 2025 |
| Feb 5, 2025 | Michael L Manelis Executive Vice President & COO | AGrant or award Common Shares Of Beneficial Interest | +6,070 | $0.00 | $0 | 36,268 | Feb 7, 2025 |
| Feb 6, 2025 | Robert Garechana EVP & Chief Financial Officer | SOpen-market sale Common Shares Of Beneficial Interest | -1,693 | $72.06 | $122k | 16,709 | Feb 7, 2025 |
| Feb 6, 2025 | Scott Fenster EVP & General Counsel | SOpen-market sale Common Shares Of Beneficial Interest | -1,955 | $72.06 | $141k | 38,892 | Feb 7, 2025 |
| Feb 6, 2025 | Michael L Manelis Executive Vice President & COO | SOpen-market sale Common Shares Of Beneficial Interest | -3,404 | $72.06 | $245k | 32,864 | Feb 7, 2025 |
| Feb 6, 2025 | Robert Garechana EVP & Chief Financial Officer | SOpen-market sale Common Shares Of Beneficial Interest | -2,601 | $72.06 | $187k | 14,108 | Feb 7, 2025 |
| Feb 5, 2025 | Barry Altshuler Executive Vice President | AGrant or award Restricted Unitsderivative | +3,967 | $0.00 | $0 | 3,967 | Feb 7, 2025 |
| Feb 6, 2025 | Scott Fenster EVP & General Counsel | SOpen-market sale Common Shares Of Beneficial Interest | -3,385 | $72.06 | $244k | 35,507 | Feb 7, 2025 |
| Feb 5, 2025 | Stephen E Sterrett director | SOpen-market sale Common Shares Of Beneficial Interest | -2,101 | $72.21 | $152k | 19,395 | Feb 7, 2025 |
| Feb 6, 2025 | Catherine Carraway EVP & CHRO | SOpen-market sale Common Shares Of Beneficial Interest | -483 | $72.06 | $35k | 14,115 | Feb 7, 2025 |
| Feb 5, 2025 | Mark J. Parrell President & CEO | AGrant or award Restricted Unitsderivative | +22,095 | $0.00 | $0 | 22,095 | Feb 7, 2025 |
| Feb 6, 2025 | Alexander Brackenridge Executive Vice President & CIO | SOpen-market sale Common Shares Of Beneficial Interest | -5,689 | $72.06 | $410k | 89,279 | Feb 7, 2025 |
| Feb 6, 2025 | Ian Kaufman Chief Accounting Officer | SOpen-market sale Common Shares Of Beneficial Interest | -642 | $72.06 | $46k | 25,539 | Feb 7, 2025 |
| Feb 6, 2025 | Michael L Manelis Executive Vice President & COO | SOpen-market sale Common Shares Of Beneficial Interest | -1,833 | $72.06 | $132k | 31,031 | Feb 7, 2025 |
| Feb 6, 2025 | Catherine Carraway EVP & CHRO | SOpen-market sale Common Shares Of Beneficial Interest | -362 | $72.06 | $26k | 13,753 | Feb 7, 2025 |
| Feb 6, 2025 | Alexander Brackenridge Executive Vice President & CIO | SOpen-market sale Common Shares Of Beneficial Interest | -6,770 | $72.06 | $488k | 82,509 | Feb 7, 2025 |
| Feb 6, 2025 | Michael L Manelis Executive Vice President & COO | SOpen-market sale Common Shares Of Beneficial Interest | -4,250 | $72.09 | $306k | 26,781 | Feb 7, 2025 |
| Feb 5, 2025 | Stephen E Sterrett director | MOption exercise Non-qualified Stock Option (Right to Buy)derivative | -2,101 | $0.00 | $0 | 0 | Feb 7, 2025 |
| Feb 5, 2025 | Robert Garechana EVP & Chief Financial Officer | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +27,199 | $0.00 | $0 | 27,199 | Feb 7, 2025 |
| Feb 5, 2025 | Scott Fenster EVP & General Counsel | AGrant or award Restricted Unitsderivative | +12,197 | $0.00 | $0 | 12,197 | Feb 7, 2025 |
| Feb 5, 2025 | Robert Garechana EVP & Chief Financial Officer | AGrant or award Restricted Unitsderivative | +15,891 | $0.00 | $0 | 15,891 | Feb 7, 2025 |
| Feb 5, 2025 | Michael L Manelis Executive Vice President & COO | AGrant or award Restricted Unitsderivative | +19,313 | $0.00 | $0 | 19,313 | Feb 7, 2025 |
| Jan 17, 2025 | Alexander Brackenridge Executive Vice President & CIO | AGrant or award Common Shares Of Beneficial Interest | +15,308 | $0.00 | $0 | 73,997 | Jan 22, 2025 |
| Jan 17, 2025 | Catherine Carraway EVP & CHRO | AGrant or award Common Shares Of Beneficial Interest | +2,185 | $0.00 | $0 | 12,564 | Jan 22, 2025 |
| Jan 17, 2025 | Scott Fenster EVP & General Counsel | AGrant or award Common Shares Of Beneficial Interest | +7,654 | $0.00 | $0 | 40,847 | Jan 22, 2025 |
| Jan 17, 2025 | Robert Garechana EVP & Chief Financial Officer | AGrant or award Common Shares Of Beneficial Interest | +3,826 | $0.00 | $0 | 18,402 | Jan 22, 2025 |
| Jan 17, 2025 | Michael L Manelis Executive Vice President & COO | AGrant or award Common Shares Of Beneficial Interest | +4,145 | $0.00 | $0 | 30,198 | Jan 22, 2025 |
| Jan 17, 2025 | Mark J. Parrell President & CEO | AGrant or award Restricted Unitsderivative | +68,655 | $0.00 | $0 | 68,655 | Jan 22, 2025 |
| Jan 17, 2025 | Michael L Manelis Executive Vice President & COO | AGrant or award Restricted Unitsderivative | +12,908 | $0.00 | $0 | 12,908 | Jan 22, 2025 |
| Jan 17, 2025 | Robert Garechana EVP & Chief Financial Officer | AGrant or award Restricted Unitsderivative | +11,915 | $0.00 | $0 | 11,915 | Jan 22, 2025 |
| Nov 14, 2024 | Ian Kaufman Chief Accounting Officer | AGrant or award Common Shares Of Beneficial Interest | +31 | $62.11 | $1,925 | 22,354 | Nov 18, 2024 |
| Nov 7, 2024 | Michael L Manelis Executive Vice President & COO | SOpen-market sale Common Shares Of Beneficial Interest | -2,000 | $71.50 | $143k | 26,053 | Nov 12, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Barry AltshulerExecutive Vice President
- Alexander BrackenridgeExecutive Vice President & CIO
- Chris Carrdirector
- Catherine CarrawayEVP & CHRO
- Scott FensterEVP & General Counsel
- Robert GarechanaEVP & Chief Financial Officer
- Ian KaufmanChief Accounting Officer
- Michael L ManelisExecutive Vice President & COO
- David J Neithercutdirector
- Mark J. ParrellPresident & CEO
- Mark S Shapirodirector, officer
- Stephen E Sterrettdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.